Table I.
Indication for FDG PET/CT (n=56).
| Primary disease | Patients, n | Indication for FDG PET/CT |
|---|---|---|
| Colorectal cancer | 16 | In 15 patients, imaging was performed as part of surveillance or due to increased levels of CEA. One patient had a known metastatic disease without bowel sites of disease |
| Non-Hodgkin lymphoma | 14 | Staging Assessment of new suspicious lesions |
| Breast cancer | 5 | Suspected metastatic disease |
| Lung cancer | 7 | Staging |
| Melanoma | 3 | Staging Response to systemic treatment |
| Hodgkin lymphoma | 2 | Surveillance |
| Bladder cancer | 2 | Assessment of new lung lesion Assessment of response to systemic treatment |
| Malignant hystiocytoma | 1 | Suspected recurrence |
| Gastric cancer | 1 | Suspected lesions in the lung and liver |
| Cervix cancer | 1 | Surveillance |
| Pancreatic cancer | 1 | Staging |
| Tongue cancer | 1 | Staging |
| Skin squamous cell cancer | 1 | Staging |
| Fever of unknown origin | 1 | To determine to source of prolonged fever |
FDG PET/CT, fluorodeoxyglucose positron emission tomography/computed tomography; CEA, carcinoembryonic antigen.